Pulmonx
Gaelle Flammang-Dorie has extensive experience in marketing, with a focus on EMEA regions. Gaelle has held various marketing and leadership roles in companies such as Pulmonx Corporation, Medtronic, Halyard Health, and more. Gaelle's educational background includes a Master's degree in International Management from Université Rennes and coursework in Advertising and Monetary Theory from the University of California, Berkeley.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1